miRNA ID |
Editing Sites |
Enzyme |
Editing Type |
Molecular Consequence |
Editing-Level |
Target Change |
Correlation |
Phenotype |
Disease |
hsa-mir-214 |
2 |
ADAR2 |
U-to-C |
miRNA and its target gene expression change |
Increased |
|
- |
Occur in tumor |
|
hsa-mir-122 |
1 |
ADAR2 |
A-to-I |
miRNA and its target gene expression change |
Increased |
|
- |
Occur in tumor |
|
hsa-miR-200b |
1 |
ADAR1;ADAR2 |
A-to-I |
- |
Increased |
- TP53->TP53
- BRAF->BRAF
- NRAS->NRAS
- CDH1->CDH1
- ZEB1->ZEB1
- ZEB2->ZEB2
- LIFR->LIFR
|
- |
Inhibit survival capability |
|
hsa-miR-99a |
1 |
ADAR1;ADAR3 |
A-to-I |
- |
Increased |
- TP53->TP53
- PIK3CA->PIK3CA
- MAP3K1->MAP3K1
- HRAS->HRAS
- NRAS->NRAS
|
Positive |
Affect disease |
|
hsa-miR-376a |
1 |
ADAR1 |
A-to-I |
Retargeting of miRNA |
Increased |
|
Positive |
Promote tumor migration and invasion |
|
hsa-miR-455-5p |
2 |
ADAR1 |
A-to-I |
Target gene expression change |
Absent |
|
Negative |
Inhibit tumor growth and metastasis |
|
hsa-let-7a-1 |
2 |
ADAR1 |
A-to-I |
Regulate miRNA biogenesis |
Increased |
|
Negative |
Promote survival capability |
|
hsa-miR-132-3p |
2 |
- |
A-to-I |
miRNA expression change |
Increased |
|
Positive |
Affect disease |
|
hsa-mir-27b |
1 |
- |
A-to-I |
- |
Increased |
|
Positive |
Promote plasma levels of high-density lipoprotein |
|
hsa-miR-605 |
1 |
- |
A-to-I |
- |
Increased |
|
Positive |
Promote plasma levels of high-density lipoprotein |
|
hsa-miR-378a-3p |
1 |
ADAR1 |
A-to-I |
Target gene expression change |
Increased |
|
Positive |
Inhibit tumor progression |
|
hsa-miR-589-3p |
3 |
ADAR2 |
A-to-I |
Retargeting of miRNA |
Increased |
|
Negative |
Inhibit tumor proliferation, migration and invasion |
|
hsa-miR-221 |
2 |
ADAR2 |
A-to-I |
miRNA expression change |
Increased |
|
Positive |
Affect tumor migration and invasion |
|
hsa-miR-222 |
2 |
ADAR2 |
A-to-I |
miRNA expression change |
Increased |
|
Positive |
Affect tumor migration and invasion |
|
hsa-miR-381 |
2 |
ADAR2 |
A-to-I |
miRNA expression change |
Increased |
|
Positive |
Affect tumor migration and invasion |
|
hsa-miR-142-3p |
1 |
ADAR2 |
U-to-C |
miRNA expression change |
Increased |
|
Positive |
Affect cell migration and proliferation |
|
has-mir-3157
|
1 |
ADAR1
|
A-to-G
|
miRNA and its target gene expression change
|
Increase
|
|
Positive
|
Affect the pathogenesis of the disease
|
|
has-mir-6503
|
1 |
ADAR1
|
A-to-G
|
miRNA and its target gene expression change
|
Increase
|
|
Positive
|
Affect the pathogenesis of the disease
|
|
has-mir-200b
|
1 |
ADAR1 |
A-to-G |
miRNA and its target gene expression change
|
Increase
|
|
Positive
|
Its levels of editing correlate with a worse progression-free survival and disease stage
|
|
has-mir-149 |
1 |
ADAR1 |
A-to-G |
miRNA and its target gene expression change |
Increase |
|
Positive
|
miRNA-149 is considered as both a bio-marker and a therapeutic target for treatment of mel |
|